The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Exact Sciences
Leadership - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
NSAB C-14: CORRECT-MRD II—Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease.
 
Mohamed E. Salem
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; Exelixis; Novartis; Pfizer; QED Therapeutics; Taiho Pharmaceutical
Speakers' Bureau - BMS; Daiichi Sankyo/Astra Zeneca; Merck; Taiho Pharmaceutical
 
Shannon Leigh Huggins-Puhalla
Consulting or Advisory Role - Abbvie; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Pfizer (Inst)
 
Thomas J. George
Consulting or Advisory Role - Pfizer; Tempus
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Melanie R. Palomares
Employment - Exact Sciences
Leadership - Cancer Prevention Movement
Stock and Other Ownership Interests - Exact Sciences; LabCorp
Travel, Accommodations, Expenses - Exact Sciences
 
Frederick L Baehner
No Relationships to Disclose
 
Norman Wolmark
No Relationships to Disclose